Fractyl Health Stock
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
Sign up today and learn more about Fractyl Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Fractyl Health Stock
Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with better solutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers. Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.
Co-Founder & CEO
Co-founder & President
Chief Financial Officer
Vice President of Quality Assurance and Regulatory Affairs
Chief Medical Officer
Juan Carlos Lopez-Talavera
William W. Bradley
Chief Commercial Officer
Member Board of Directors
Vice President of Manufacturing
Ajay Gopal Royan